These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives]. Cianci A; De Leo V Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832 [TBL] [Abstract][Full Text] [Related]
4. Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol. Akerlund M Acta Obstet Gynecol Scand Suppl; 1997; 164():63-5. PubMed ID: 9225641 [TBL] [Abstract][Full Text] [Related]
5. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12". Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253 [TBL] [Abstract][Full Text] [Related]
6. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity. Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323 [TBL] [Abstract][Full Text] [Related]
7. The misunderstood pill: thirty years of testing and development have reduced pill's major, minor side effects. United States. Centers for Disease Control CDC. Advisory Committee on Immunization Practices Netw Res Triangle Park N C; 1986; 7(4):1-5. PubMed ID: 12341093 [TBL] [Abstract][Full Text] [Related]
8. An update on the pill. Initiatives Popul; 1983; 7(3):2-15. PubMed ID: 12339841 [TBL] [Abstract][Full Text] [Related]
9. [Cardiovascular risks of oral contraceptives: dose-response relationship]. Kelleher CC Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220 [TBL] [Abstract][Full Text] [Related]
11. Oral contraceptives for the prevention of osteoporosis. Corson SL J Reprod Med; 1993 Dec; 38(12 Suppl):1015-20. PubMed ID: 8120858 [TBL] [Abstract][Full Text] [Related]
12. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs. Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738 [TBL] [Abstract][Full Text] [Related]
13. Compliance, counseling and satisfaction with oral contraceptives: a prospective evaluation. Rosenberg MJ; Waugh MS; Burnhill MS Fam Plann Perspect; 1998; 30(2):89-92, 104. PubMed ID: 9561874 [TBL] [Abstract][Full Text] [Related]
14. [Combined contraceptives and cardiovascular risk]. Belaisch J; Hommais-loufrani B Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199 [TBL] [Abstract][Full Text] [Related]
15. Risks of oral contraceptive use in women over 35. Stenchever MA J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860 [TBL] [Abstract][Full Text] [Related]
16. Depo Provera. Position paper on clinical use, effectiveness and side effects. Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658 [TBL] [Abstract][Full Text] [Related]
17. Effect of oestrogen dose on whole blood platelet activation in women taking new low dose oral contraceptives. Norris LA; Bonnar J Thromb Haemost; 1994 Dec; 72(6):926-30. PubMed ID: 7740465 [TBL] [Abstract][Full Text] [Related]
18. Statement on steroidal oral contraceptives. International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP IPPF Med Bull; 1981 Dec; 15(6):3-5. PubMed ID: 12263973 [TBL] [Abstract][Full Text] [Related]